Heron Therapeutics (HRTX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 12, 2025, at 9:00 AM ET, to be held virtually.

• Shareholders are encouraged to review proxy materials and vote by June 11, 2025.

Voting matters and shareholder proposals

• Election of six director nominees to serve until the 2026 annual meeting.

• Ratification of Withum as independent registered public accounting firm for fiscal year ending December 31, 2025.

• Advisory vote on executive compensation for the fiscal year ended December 31, 2024.

• Advisory vote on the frequency of future executive compensation votes, with a recommendation for annual votes.

• Provision to transact other business as may properly come before the meeting.

Board of directors and corporate governance

• Six nominees for director positions: Craig Collard, Sharmila Dissanaike, Craig Johnson, Michael Kaseta, Adam Morgan, and Christian Waage.